Private Equity Firm Healthcare

Truehelm

Bloomington, Minnesota, United States

Formerly known as TT Capital Partners, TT Capital Partners LLC, tt capital partners

Truehelm partners with healthcare IT and tech-enabled services companies poised for growth and market leadership, aligning capital and operational guidance to accelerate growth.

Focus Areas
Healthcare IT, Technology-enabled services
Website
truehelm.com

Tracked deals

7

7 tracked deals across 2019-2025.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Growth capital

4 growth capital · 2 buyout · 1 recapitalization

Truehelm Acquisition Volume by Year

Last 6 years

Acquisition volume by year Annual acquisition counts for the last 6 years for Truehelm. 1 2019 1 2020 2 2021 1 2023 1 2024 1 2025

Supporting Data

Recent Transactions

  • Buyer
    Pyx Health, S2G Investments, TT Capital Partners
    Target
    FarmboxRx
    Seller
    Farmbox Direct, Inc.
    Type
    Buyout

    Pyx Health has acquired FarmboxRx after receiving a $47.5 million investment from S2G Investments in strategic partnership with TT Capital Partners. The deal integrates FarmboxRx's customized food-box solutions into Pyx Health's mentor-driven care navigation platform to address food insecurity and strengthen member engagement for health plans, particularly in Medicare and Medicaid populations.

  • Buyer
    TT Capital Partners
    Target
    Collaborating Docs
    Type
    Buyout

    TT Capital Partners announced a majority investment in Collaborating Docs, a Columbus-based company that matches nurse practitioners with supervising physicians and provides related administrative, compliance, and payment services. The investment will support scaling operations, expanding services to other advanced practice providers and enterprise customers, and accelerating growth under founder Dr. Annie DePasquale.

  • Buyer
    TT Capital Partners
    Target
    Pyx Health
    Seller
    Rallyday Partners

    Pyx Health, a tech-enabled services company addressing loneliness and social determinants of health, received a majority growth/recapitalization investment from TT Capital Partners. Rallyday Partners exited its stake as part of the transaction; financial terms were not disclosed. TTCP said it will support Pyx Health’s next stage of growth by leveraging sector relationships and operational capabilities to scale the business.

  • Buyer
    TT Capital Partners
    Target
    MediStreams

    TT Capital Partners has made a growth equity investment in MediStreams to fund product development and accelerate growth. MediStreams, founded in 2009 and headquartered in Roswell, Georgia, provides remittance, reconciliation and payment automation revenue cycle management solutions to healthcare providers and will use the investment to scale its technology-enabled services and go-to-market.

  • Buyer
    TT Capital Partners
    Target
    Propio Language Services

    TT Capital Partners has made a growth equity investment in Propio Language Services to accelerate development of Propio’s Propio ONE platform, expand strategic hiring, and scale its interpretation, translation, and localization services—particularly in healthcare where ~70% of Propio’s business resides. The funding is Propio’s first external investment and will support product innovation, broader adoption of remote language services, and continued company growth.

  • Buyer
    NewSpring Healthcare, TT Capital Partners
    Target
    MacroHealth Solutions

    NewSpring Healthcare, the dedicated healthcare strategy of NewSpring, has invested in MacroHealth Solutions in partnership with TT Capital Partners. The growth investment will fund MacroHealth's technology and operations expansion to accelerate product development, engineering hires, and go-to-market efforts for its enterprise health-market-as-a-service platform.

  • Buyer
    TT Capital Partners, NovaQuest Capital Management, Frist Cressey Ventures
    Target
    InformedDNA

    InformedDNA, the U.S. leader in genetics services, has entered definitive agreements with TT Capital Partners, NovaQuest Capital Management, and Frist Cressey Ventures to receive a growth capital investment to scale its technology-enabled genetic services and expand its genetic counseling staff. Terms were not disclosed; InformedDNA will remain led by CEO David Nixon and has also secured a flexible credit facility from CIBC.

Related Acquisition Pages

Selling a company? Get in front of buyers like Truehelm

Turn tracked acquisition activity into an outreach-ready buyer list.